Format
Items per page
Sort by

Send to:

Choose Destination

Results: 6

1.

Novel iboga alkaloid congeners block nicotinic receptors and reduce drug self-administration.

Pace CJ, Glick SD, Maisonneuve IM, He LW, Jokiel PA, Kuehne ME, Fleck MW.

Eur J Pharmacol. 2004 May 25;492(2-3):159-67.

PMID:
15178360
[PubMed - indexed for MEDLINE]
2.

Iboga interactions with psychomotor stimulants: panacea in the paradox?

Szumlinski KK, Maisonneuve IM, Glick SD.

Toxicon. 2001 Jan;39(1):75-86. Review.

PMID:
10936624
[PubMed - indexed for MEDLINE]
3.

Mechanisms of antiaddictive actions of ibogaine.

Glick SD, Maisonneuve IS.

Ann N Y Acad Sci. 1998 May 30;844:214-26. Review.

PMID:
9668680
[PubMed - indexed for MEDLINE]
4.

Drug discrimination studies with ibogaine.

Helsley S, Rabin RA, Winter JC.

Alkaloids Chem Biol. 2001;56:63-77. Review.

PMID:
11705117
[PubMed - indexed for MEDLINE]
5.

Mechanisms of action of ibogaine: relevance to putative therapeutic effects and development of a safer iboga alkaloid congener.

Glick SD, Maisonneuve IM, Szumlinski KK.

Alkaloids Chem Biol. 2001;56:39-53. Review. No abstract available.

PMID:
11705115
[PubMed - indexed for MEDLINE]
6.

The Anti-Addiction Drug Ibogaine and the Heart: A Delicate Relation.

Koenig X, Hilber K.

Molecules. 2015 Jan 29;20(2):2208-2228. Review.

PMID:
25642835
[PubMed - as supplied by publisher]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk